Latham and Goodwin Procter persuaded the Federal Circuit that CareDx patents for detecting organ transplant rejection are invalid because they apply a natural law using conventional techniques. Weil Gotshal argues that the patented techniques are anything but conventional, and that the decision will "suffocate innovation in the life-saving arts.”
July 18, 2022 at 04:44 PM
3 minute read
The Federal Circuit has held patents on a noninvasive test for detecting organ transplant rejection ineligible for patent protection.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
At NJM, a top-rated insurance company, we are seeking an Attorney on our Workers Compensation legal team with between 3 and 5 years of expe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
Judge Alan Lourie of the U.S. Court of Appeals for the Federal Circuit. Photo: Diego M. Radzinschi/ALM
